Over $700,000 for a drug per year seems excessive. There is a balance between a drug company getting back their research and development costs and having a drug that is affordable . Some of the niche drugs for rare conditions can have a profound impact on health care plan’s bottom line.
Read more about this topic here:
http://amp.timeinc.net/
